DRMA
DRMA vs Historical averages
| Metric | Current | Average | Relative |
|---|---|---|---|
| EPS | -$4.39 | -$1,082.07 | $1,077.68 higher |
| FCF | -$8.1M | -$7.6M | -$573.8K |
| Loading historical comparisons… | |||
DRMA’s earnings are above their historical averages.
DRMA Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Loss narrowing |
| Forward revenue | -- |
| Forward profitability | -- |
| Analyst coverage | Limited |
| Estimate dispersion | Tight |
DRMA’s available outlook is mixed, though analyst coverage is limited.
DRMA PE Valuation
This table applies DRMA's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
DRMA Earnings Per Share
This chart tracks DRMA's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
DRMA Quarterly Revenue
This chart tracks DRMA's quarterly revenue over time and shows how sales are changing from year to year.
DRMA Free Cash Flow
This chart tracks DRMA's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
DRMA Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
DRMA PE vs Healthcare Sector
This chart compares DRMA's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
DRMA Weekly Price
This chart uses DRMA's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
DRMA Weekly Moving Averages
This chart compares DRMA's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
DRMA Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.